Results 131 to 140 of about 82,620 (274)
Revista Brasileira de Hematologia e HemoterapiaBackground Distinction between mature B-cell neoplasms can be difficult due to overlapping of immunologic features and clinical manifestations. This study investigated whether quantifying mean fluorescence intensity of four monoclonal antibodies in a ...
Elissandra Machado Arlindo +3 more
doaj +1 more source
A Human Alloantiserum Precipitates Ia-Like Molecules from Chronic Lymphocytic Leukemia Cells [PDF]
, 1977 Sten Nilsson +5 more
openalex +1 more source
Molecular Carcinogenesis, Volume 62, Issue 1, Page 101-112, January 2023., 2023 Abstract Merkel cell carcinoma (MCC) is a rare, highly aggressive cutaneous neuroendocrine carcinoma. Controversy exists regarding optimal management of MCC as high‐quality randomized studies and clinical trials are limited, and physicians are bound to interpret highly heterogeneous, retrospective literature in their clinical practice. Furthermore, the
Daniela Duarte‐Bateman +6 more
wiley +1 more source
A mathematical model of clonal hematopoiesis explaining phase transitions in myeloid leukemia [PDF]
arXivThis study presents a mathematical model describing cloned hematopoiesis in chronic myeloid leukemia (CML) through a nonlinear system of differential equations. The primary objective is to understand the progression from normal hematopoiesis to the chronic and accelerated-acute phases in myeloid leukemia.
arxiv
Poor Mixed Lymphocyte Reaction Stimulatory Capacity of Leukemic B Cells of Chronic Lymphocytic Leukemia Patients Despite the Presence of Ia Antigens [PDF]
, 1979 James P. Halper +4 more
openalex +1 more source
Breaking barriers: Smart vaccine platforms for cancer immunomodulation
Cancer Communications, EarlyView.Abstract Despite significant advancements in cancer treatment, current therapies often fail to completely eradicate malignant cells. This shortfall underscores the urgent need to explore alternative approaches such as cancer vaccines. Leveraging the immune system's natural ability to target and kill cancer cells holds great therapeutic potential ...
Mohammad Mahmoudi Gomari +11 more
wiley +1 more source
Further characterization of the circulating cell in chronic lymphocytic leukemia [PDF]
, 1976 EF Schultz, S Davis, AD Rubin
openalex +1 more source
Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunities
Cancer Communications, EarlyView.Abstract Copper, one of the essential nutrients for the human body, acts as an electron relay in multiple pathways due to its redox properties. Both deficiencies and excesses of copper lead to cellular fragility. Therefore, it can manifest pro‐ and anti‐cancer properties in tumors. Therefore, it is crucial to clarify the copper activity within the cell.
Dan Shan +13 more
wiley +1 more source
Comparison of daily versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemia [PDF]
, 1977 A Sawitsky +3 more
openalex +1 more source